Telomeric repeat-containing RNA (TERRA) constitutes a nucleoprotein component of extracellular inflammatory exosomes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 46, 2015, Pages E6293-E6300

  Wang, Zhuo ^a,b   Deng, Zhong ^a   Dahmane, Nadia ^c   Tsai, Kevin ^a   Wang, Pu ^a   Williams, Dewight R ^c   Kossenkov, Andrew V ^a   Showe, Louise C ^a   Zhang, Rugang ^a   Huang, Qihong ^a   Conejo Garcia, José R ^a   Lieberman, Paul M ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF THE SCIENCES   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cytokine; Exosome; Innate immunity; Telomere; TERRA

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR10; CYTOKINE; HISTONE; INTERLEUKIN 6; NUCLEOPROTEIN; RNA; TELOMERIC REPEAT CONTAINING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CD63 ANTIGEN; CD63 PROTEIN, HUMAN; CD83 ANTIGEN; IMMUNOGLOBULIN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; UNTRANSLATED RNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CRYOELECTRON MICROSCOPY; CULTURE MEDIUM; ELECTRON MICROSCOPY; EMBRYO; EXOSOME; INNATE IMMUNITY; LYMPHOBLASTOID CELL; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA HYBRIDIZATION; TELOMERE; TUMOR MICROENVIRONMENT; ANIMAL; BLOOD; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; NEOPLASM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD63; CELL LINE, TUMOR; CYTOKINES; EXOSOMES; HISTONES; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULINS; INFLAMMATION; MEMBRANE GLYCOPROTEINS; MICE; NEOPLASMS; RNA, UNTRANSLATED; SIGNAL TRANSDUCTION; TELOMERE;

EID: 84966267338     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1505962112     Document Type: Article

References (67)

1. Blackburn EH, Greider CW, Szostak JW (2006) Telomeres and telomerase: The path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 12(10): 1133-1138.
2. Cech TR (2004) Beginning to understand the end of the chromosome. Cell 116(2): 273-279.
3. Palm W, de Lange T (2008) How shelterin protects mammalian telomeres. Annu Rev Genet 42:301-334.
4. O'Sullivan RJ, Karlseder J (2010) Telomeres: Protecting chromosomes against genome instability. Nat Rev Mol Cell Biol 11(3):171-181.
5. Braig M, et al. (2014) A 'telomere-associated secretory phenotype' cooperates with BCR-ABL to drive malignant proliferation of leukemic cells. Leukemia 28(10):2028-2039.
6. Fumagalli M, et al. (2012) Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation. Nat Cell Biol 14(4):355-365.
7. Schoeftner S, Blasco MA (2008) Developmentally regulated transcription of mammalian telomeres by DNA-dependent RNA polymerase II. Nat Cell Biol 10(2):228-236.
8. Azzalin CM, Reichenbach P, Khoriauli L, Giulotto E, Lingner J (2007) Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science 318(5851):798-801.
9. Azzalin CM, Lingner J (2015) Telomere functions grounding on TERRA firma. Trends Cell Biol 25(1):29-36.
10. Maicher A, Lockhart A, Luke B (2014) Breaking new ground: Digging into TERRA function. Biochim Biophys Acta 1839(5):387-394.
11. Flynn RL, et al. (2011) TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA. Nature 471(7339):532-536.
12. Deng Z, Norseen J, Wiedmer A, Riethman H, Lieberman PM (2009) TERRA RNA binding to TRF2 facilitates heterochromatin formation and ORC recruitment at telomeres. Mol Cell 35(4):403-413.
13. Arora R, et al. (2014) RNaseH1 regulates TERRA-telomeric DNA hybrids and telomere maintenance in ALT tumour cells. Nat Commun 5:5220.
14. Balk B, et al. (2013) Telomeric RNA-DNA hybrids affect telomere-length dynamics and senescence. Nat Struct Mol Biol 20(10):1199-1205.
15. Schoeftner S, et al. (2009) Telomere shortening relaxes X chromosome inactivation and forces global transcriptome alterations. Proc Natl Acad Sci USA 106(46):19393-19398.
16. Zhang LF, et al. (2009) Telomeric RNAs mark sex chromosomes in stem cells. Genetics 182(3):685-698.
17. Deng Z, et al. (2012) Formation of telomeric repeat-containing RNA (TERRA) foci in highly proliferating mouse cerebellar neuronal progenitors and medulloblastoma. J Cell Sci 125(Pt 18):4383-4394.
18. Xu Y, Komiyama M (2012) Structure, function and targeting of human telomere RNA. Methods 57(1):100-105.
19. Takahama K, et al. (2013) Regulation of telomere length by G-quadruplex telomere DNA- and TERRA-binding protein TLS/FUS. Chem Biol 20(3):341-350.
20. Barbalat R, Ewald SE, Mouchess ML, Barton GM (2011) Nucleic acid recognition by the innate immune system. Annu Rev Immunol 29:185-214.
21. Gursel I, et al. (2003) Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation. J Immunol 171(3):1393-1400.
22. Mansour H (2014) Cell-free nucleic acids as noninvasive biomarkers for colorectal cancer detection. Front Genet 5:182.
23. Théry C, Zitvogel L, Amigorena S (2002) Exosomes: Composition, biogenesis and function. Nat Rev Immunol 2(8):569-579.
24. Robbins PD, Morelli AE (2014) Regulation of immune responses by extracellular vesicles. Nat Rev Immunol 14(3):195-208.
25. Théry C (2011) Exosomes: Secreted vesicles and intercellular communications. F1000 Biol Rep 3:15.
26. Ji H, et al. (2013) Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components. Proteomics 13(10-11):1672-1686.
27. Laulagnier K, et al. (2004) Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization. Biochem J 380(Pt 1):161-171.
28. Tomasoni S, et al. (2013) Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. Stem Cells Dev 22(5): 772-780.
29. Valadi H, et al. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6):654-659.
30. Denzer K, Kleijmeer MJ, Heijnen HF, Stoorvogel W, Geuze HJ (2000) Exosome: From internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci 113(Pt 19):3365-3374.
31. Théry C, Ostrowski M, Segura E (2009) Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9(8):581-593.
32. Umezu T, Ohyashiki K, Kuroda M, Ohyashiki JH (2013) Leukemia cell to endothelial cell communication via exosomal miRNAs. Oncogene 32(22):2747-2755.
33. Dreux M, et al. (2012) Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe 12(4): 558-570.
34. Lundholm M, et al. (2014) Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: Mechanism of immune evasion. PLoS One 9(9):e108925.
35. Atay S, et al. (2014) Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion. Proc Natl Acad Sci USA 111(2):711-716.
36. Caby MP, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C (2005) Exosomallike vesicles are present in human blood plasma. Int Immunol 17(7):879-887.
37. Verweij FJ, et al. (2011) LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-êB activation. EMBO J 30(11):2115-2129.
38. Beninson LA, Fleshner M (2014) Exosomes: An emerging factor in stress-induced immunomodulation. Semin Immunol 26(5):394-401.
39. Suram A, Herbig U (2014) The replicometer is broken: Telomeres activate cellular senescence in response to genotoxic stresses. Aging Cell 13(5):780-786.
40. Armanios M, Blackburn EH (2012) The telomere syndromes. Nat Rev Genet 13(10): 693-704.
41. Falandry C, Bonnefoy M, Freyer G, Gilson E (2014) Biology of cancer and aging: A complex association with cellular senescence. J Clin Oncol 32(24):2604-2610.
42. Reddel RR (2014) Telomere maintenance mechanisms in cancer: Clinical implications. Curr Pharm Des 20(41):6361-6374.
43. Velarde MC, Demaria M, Campisi J (2013) Senescent cells and their secretory phenotype as targets for cancer therapy. Interdiscip Top Gerontol 38:17-27.
44. Coppé JP, et al. (2008) Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6(12):2853-2868.
45. Porro A, et al. (2014) Functional characterization of the TERRA transcriptome at damaged telomeres. Nat Commun 5:5379.
46. Caslini C, Connelly JA, Serna A, Broccoli D, Hess JL (2009) MLL associates with telomeres and regulates telomeric repeat-containing RNA transcription. Mol Cell Biol 29(16):4519-4526.
47. Deng Z, et al. (2014) HSV-1 remodels host telomeres to facilitate viral replication. Cell Reports 9(6):2263-2278.
48. Cusanelli E, Romero CA, Chartrand P (2013) Telomeric noncoding RNA TERRA is induced by telomere shortening to nucleate telomerase molecules at short telomeres. Mol Cell 51(6):780-791.
49. Schoeftner S, Blasco MA (2010) Chromatin regulation and non-coding RNAs at mammalian telomeres. Semin Cell Dev Biol 21(2):186-193.
50. Porro A, Feuerhahn S, Lingner J (2014) TERRA-reinforced association of LSD1 with MRE11 promotes processing of uncapped telomeres. Cell Reports 6(4):765-776.
51. Georgin-Lavialle S, et al. (2010) The telomere/telomerase system in autoimmune and systemic immune-mediated diseases. Autoimmun Rev 9(10):646-651.
52. Wong JY, De Vivo I, Lin X, Fang SC, Christiani DC (2014) The relationship between inflammatory biomarkers and telomere length in an occupational prospective cohort study. PLoS One 9(1):e87348.
53. Bhattacharjee RN, Banerjee B, Akira S, Hande MP (2010) Telomere-mediated chromosomal instability triggers TLR4 induced inflammation and death in mice. PLoS One 5(7):e11873.
54. Sebastián C, et al. (2009) Telomere shortening and oxidative stress in aged macrophages results in impaired STAT5a phosphorylation. J Immunol 183(4):2356-2364.
55. Morgan RG, et al. (2013) Age-related telomere uncapping is associated with cellular senescence and inflammation independent of telomere shortening in human arteries. Am J Physiol Heart Circ Physiol 305(2):H251-H258.
56. Biroccio A, et al. (2013) TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells. Nat Cell Biol 15(7):818-828.
57. Ishii KJ, Akira S (2006) Innate immune recognition of, and regulation by, DNA. Trends Immunol 27(11):525-532.
58. Yagci FC, et al. (2010) Mammalian telomeric DNA suppresses endotoxin-induced uveitis. J Biol Chem 285(37):28806-28811.
59. Lenert PS (2010) Classification, mechanisms of action, and therapeutic applications of inhibitory oligonucleotides for Toll-like receptors (TLR) 7 and 9. Mediators Inflamm 2010:986596.
60. Shirota H, Gursel M, Klinman DM (2004) Suppressive oligodeoxynucleotides inhibit Th1 differentiation by blocking IFN-gamma- and IL-12-mediated signaling. J Immunol 173(8):5002-5007.
61. Bianchi A, de Lange T (1999) Ku binds telomeric DNA in vitro. J Biol Chem 274(30): 21223-21227.
62. Klinman DM, Tross D, Klaschik S, Shirota H, Sato T (2009) Therapeutic applications and mechanisms underlying the activity of immunosuppressive oligonucleotides. Ann N Y Acad Sci 1175:80-88.
63. Hirashima K, Seimiya H (2015) Telomeric repeat-containing RNA/G-quadruplexforming sequences cause genome-wide alteration of gene expression in human cancer cells in vivo. Nucleic Acids Res 43(4):2022-2032.
64. Thery C, Amigorena S, Raposo G, Clayton A (2006) Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Current Protocols in Cell Biology, ed Bonifacino JS (John Wiley & Sons, Somerset, NJ), Chap 3.
65. Deng Z, et al. (2012) A role for CTCF and cohesin in subtelomere chromatin organization, TERRA transcription, and telomere end protection. EMBO J 31(21):4165-4178.
66. Rigby RE, et al. (2014) RNA:DNA hybrids are a novel molecular pattern sensed by TLR9. EMBO J 33(6):542-558.
67. Dahl JA, Collas P (2009) MicroChIP: Chromatin immunoprecipitation for small cell numbers. Methods Mol Biol 567:59-74.